Antioxidant effect of short-term hormonal treatment in postmenopausal women

Maturitas

Volumn 31, Issue 2, 1999, Pages 137-142

  Clemente, Caterina ^a   Caruso, Maria Gabriella ^a   Berloco, Pasquale ^a   Notarnicola, Maria ^a   D'Attoma, Benedetta ^a   Osella, Alberto Ruben ^a   Guerra, Vito ^a   Buonsante, Angela ^b   Giannandrea, Benedetto ^b   Di Leo, Alfredo ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b Hospital 'F Iaia'   (Italy)

Author keywords

Lipid peroxides; Medrogestone; Menopause; Oral estrogens

Indexed keywords

ESTROGEN; LIPID PEROXIDE; MEDROGESTONE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPID PEROXIDATION; MENOPAUSE; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE;

CARDIOVASCULAR DISEASES; COPPER SULFATE; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; LIPID PEROXIDATION; MEDROGESTONE; MIDDLE AGED; POSTMENOPAUSE;

EQUIDAE;

EID: 0033049064     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(98)00088-7     Document Type: Article

References (18)

1. Stampfer M.J., Colditz G.A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 20:1991;47-63.
2. Barrett-Connor E., Bush T.L. Estrogen and coronary heart disease in women. J Am Med Assoc. 265:1991;1861-1867.
3. Miller V.T., Muesing R.A., Larosa J.C., Stoy D.B., Fowler S.E., Stillman R.J. Quantitative and qualitative changes in lipids, lipoproteins, apolipoprotein A-I, and sex hormone-binding globulin due to two doses of conjugated equine estrogen with and without a progestin. Obstet Gynecol. 83:1994;173-179.
4. Caruso M.G., Berloco P., Notarnicola M., Di Leo A. Lipoprotein (a) serum levels in post-menopausal treated with oral estrogen administered at different times. Horm Metab Res. 26:1994;379-382.
5. Samaan S.A., Crawford M.H. Estrogen and cardiovascular function after menopause. J Am Coll Cardiol. 26:1995;1403-1410.
6. Witzum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 88:1991;1785-1792.
7. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. New Engl J Med. 320:1989;915-924.
8. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet. 344:1994;793-795.
9. Sack M.N., Rader D.J., Cannon R.O. III Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 343:1993;269-270.
10. Tranquilli A.L., Mazzanti L., Cugini A.M., Cester N., Garzetti G.G., Romanini C. Transdermal estradiol and medroxyprogesterone acetate in hormone replacement therapy are both antioxidants. Gynecol Endocrinol. 9:1995;137-141.
11. Esterbauer H., Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186:1990;407-421.
12. Dasgupta A., Zdunek T. In vitro peroxidation of human serum catalyzed by cupric ion: antioxidant rather than prooxidant role of ascorbate. Life Sci. 50:1992;875-882.
13. Arshad M.A.Q., Bhadra S., Cohen M.R., Subbiah M.T.R. Plasma lipoprotein peroxidation potential: a test to evaluate individual susceptibility to peroxidation. Clin Chem. 37:1991;1756-1758.
14. Wong S.H.Y., Knight J.A., Hoper S.M., Zaharia O., Leach C.N. Jr., Sunderman F.W. Jr. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem. 33:1987;214-220.
15. Frei B., Stocker R., Ames B.N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA. 85:1988;9748-9752.
16. Stocks J., Gutteridge J.M.C., Sharp R.J., Dormandy T.L. The inhibition of lipid autoxidation by human serum and its relation to serum proteins and α-tocopherol. Clin Sci Mol Med. 47:1974;223-233.
17. Schröder J., Dören M., Scheneider B., Oettel M. Are the antioxidative effects of 17β-estradiol modified by concomitant administration of a progestin? Maturitas. 25:1996;133-139.
18. Clemente C., Caruso M.G., Berloco P., Buonsante A., Giannandrea B., Di Leo A. α-tocopherol and β-carotene serum levels in post-menopausal women treated with transdermal estradiol and oral medroxyprogesterone acetate. Horm Metab Res. 28:1996;558-561.